U.S. markets open in 7 hours 51 minutes

Stryker Corporation (SYK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
268.50-4.68 (-1.71%)
At close: 4:04PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close273.18
Bid0.00 x 800
Ask0.00 x 800
Day's Range268.31 - 274.31
52 Week Range196.09 - 281.16
Avg. Volume1,103,650
Market Cap101.25B
Beta (5Y Monthly)0.99
PE Ratio (TTM)49.20
EPS (TTM)5.46
Earnings DateOct 28, 2021
Forward Dividend & Yield2.52 (0.92%)
Ex-Dividend DateSep 29, 2021
1y Target Est286.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-9% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SYK

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Stryker Corporation
    Weekly Stock ListConsumers are now more willing to spend on lifestyle enhancements along with necessary spending on life-saving treatments. In addition, the survival of the Affordable Care Act has kept the ranks of insured U.S. citizens above the historical average, further increasing consumer spending on healthcare services and products. Meanwhile, companies with experience in diagnostic testing, vaccines, and antiviral medicines, as well as suppliers of protective equipment and other hospital products, should benefit from efforts to contain the coronavirus pandemic. The sector accounts for 13.0% of the S&P 500, and includes companies in the pharmaceuticals, medical devices, healthcare services, and insurance industries. The sector is underperforming the market thus far in 2021, with a gain of 12.9%. We think the sector should account for 15-17% of diversified portfolios. Here is how we use our analysts' Financial Services sector ideas in our Focus List and Model Portfolios. All stocks are rated BUY at Argus.
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more